메뉴 건너뛰기




Volumn 5, Issue 16, 2014, Pages 7198-7211

Mapping of Apoptin-interaction with BCR-ABL1, and development of apoptin-based targeted therapy

Author keywords

Apoptin; BCR ABL1; CML; Imatinib; STAT5

Indexed keywords

APOPTIN; BCR ABL PROTEIN; DECAPEPTIDE; HYBRID PROTEIN; IMATINIB; PROLINE; PROLINE RICH PROTEIN; PROTEIN; UNCLASSIFIED DRUG; BCR-ABL1 FUSION PROTEIN, HUMAN; CAPSID PROTEIN; PEPTIDE FRAGMENT; PROTEIN KINASE INHIBITOR; VP3 PROTEIN, CHICKEN ANEMIA VIRUS;

EID: 84907081649     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.2278     Document Type: Article
Times cited : (17)

References (35)
  • 1
    • 58149398623 scopus 로고    scopus 로고
    • Translation of the Philadelphia chromosome into therapy for CML
    • Druker BJ. Translation of the Philadelphia chromosome into therapy for CML. Blood. 2008; 112(13):4808-4817.
    • (2008) Blood , vol.112 , Issue.13 , pp. 4808-4817
    • Druker, B.J.1
  • 3
    • 61849163272 scopus 로고    scopus 로고
    • Molecular biology of bcr-abl1-positive chronic myeloid leukemia
    • Quintas-Cardama A and Cortes J. Molecular biology of bcr-abl1-positive chronic myeloid leukemia. Blood. 2009; 113(8):1619-1630.
    • (2009) Blood , vol.113 , Issue.8 , pp. 1619-1630
    • Quintas-Cardama, A.1    Cortes, J.2
  • 6
    • 65249185560 scopus 로고    scopus 로고
    • Mechanisms of primary and secondary resistance to imatinib in chronic myeloid leukemia
    • Quintas-Cardama A, Kantarjian HM and Cortes JE. Mechanisms of primary and secondary resistance to imatinib in chronic myeloid leukemia. Cancer Control. 2009; 16(2):122-131.
    • (2009) Cancer Control , vol.16 , Issue.2 , pp. 122-131
    • Quintas-Cardama, A.1    Kantarjian, H.M.2    Cortes, J.E.3
  • 13
    • 32544433725 scopus 로고    scopus 로고
    • Apoptin-induced cell death is modulated by Bcl-2 family members and is Apaf-1 dependent
    • Burek M, Maddika S, Burek CJ, Daniel PT, Schulze-Osthoff K and Los M. Apoptin-induced cell death is modulated by Bcl-2 family members and is Apaf-1 dependent. Oncogene. 2006; 25(15):2213-2222.
    • (2006) Oncogene , vol.25 , Issue.15 , pp. 2213-2222
    • Burek, M.1    Maddika, S.2    Burek, C.J.3    Daniel, P.T.4    Schulze-Osthoff, K.5    Los, M.6
  • 15
    • 27644584179 scopus 로고    scopus 로고
    • Cancer-specific toxicity of apoptin is independent of death receptors but involves the loss of mitochondrial membrane potential and the release of mitochondrial cell-death mediators by a Nur77-dependent pathway
    • Maddika S, Booy EP, Johar D, Gibson SB, Ghavami S and Los M. Cancer-specific toxicity of apoptin is independent of death receptors but involves the loss of mitochondrial membrane potential and the release of mitochondrial cell-death mediators by a Nur77-dependent pathway. Journal of cell science. 2005; 118(Pt 19):4485-4493.
    • (2005) Journal of cell science , vol.118 , pp. 4485-4493
    • Maddika, S.1    Booy, E.P.2    Johar, D.3    Gibson, S.B.4    Ghavami, S.5    Los, M.6
  • 18
    • 4043178615 scopus 로고    scopus 로고
    • The viral protein Apoptin associates with the anaphase-promoting complex to induce G2/M arrest and apoptosis in the absence of p53
    • Teodoro JG, Heilman DW, Parker AE and Green MR. The viral protein Apoptin associates with the anaphase-promoting complex to induce G2/M arrest and apoptosis in the absence of p53. Genes & development. 2004; 18(16):1952-1957.
    • (2004) Genes & development , vol.18 , Issue.16 , pp. 1952-1957
    • Teodoro, J.G.1    Heilman, D.W.2    Parker, A.E.3    Green, M.R.4
  • 19
    • 84855570062 scopus 로고    scopus 로고
    • Modeling of molecular interaction between apoptin, BCR-Abl and CrkL-an alternative approach to conventional rational drug design
    • Panigrahi S, Stetefeld J, Jangamreddy JR, Mandal S, Mandal SK and Los M. Modeling of molecular interaction between apoptin, BCR-Abl and CrkL-an alternative approach to conventional rational drug design. PLoS One. 2012; 7(1):e28395.
    • (2012) PLoS One , vol.7 , Issue.1 , pp. e28395
    • Panigrahi, S.1    Stetefeld, J.2    Jangamreddy, J.R.3    Mandal, S.4    Mandal, S.K.5    Los, M.6
  • 20
    • 0028410481 scopus 로고
    • Critical residues in an SH3 domain from Sem-5 suggest a mechanism for proline-rich peptide recognition
    • Lim WA and Richards FM. Critical residues in an SH3 domain from Sem-5 suggest a mechanism for proline-rich peptide recognition. Nat Struct Biol. 1994; 1(4):221-225.
    • (1994) Nat Struct Biol , vol.1 , Issue.4 , pp. 221-225
    • Lim, W.A.1    Richards, F.M.2
  • 21
  • 22
    • 68949096693 scopus 로고    scopus 로고
    • Chronic myeloid leukemia in the tyrosine kinase inhibitor era: what is the best therapy?
    • Quintas-Cardama A and Cortes J. Chronic myeloid leukemia in the tyrosine kinase inhibitor era: what is the best therapy?. Current oncology reports. 2009; 11(5):337-345.
    • (2009) Current oncology reports , vol.11 , Issue.5 , pp. 337-345
    • Quintas-Cardama, A.1    Cortes, J.2
  • 24
    • 77956522589 scopus 로고    scopus 로고
    • Remission in CML: is DNA useful?
    • Mahon FX. Remission in CML: is DNA useful? Blood. 2010; 116(8):1192.
    • (2010) Blood , vol.116 , Issue.8 , pp. 1192
    • Mahon, F.X.1
  • 27
    • 0017168760 scopus 로고
    • Properties of the K562 cell line, derived from a patient with chronic myeloid leukemia
    • Klein E, Ben-Bassat H, Neumann H, Ralph P, Zeuthen J, Polliack A and Vanky F. Properties of the K562 cell line, derived from a patient with chronic myeloid leukemia. IntJ Cancer. 1976; 18(4):421-431.
    • (1976) IntJ Cancer , vol.18 , Issue.4 , pp. 421-431
    • Klein, E.1    Ben-Bassat, H.2    Neumann, H.3    Ralph, P.4    Zeuthen, J.5    Polliack, A.6    Vanky, F.7
  • 28
    • 0016640079 scopus 로고
    • Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome
    • Lozzio CB and Lozzio BB. Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome. Blood. 1975; 45(3):321-334.
    • (1975) Blood , vol.45 , Issue.3 , pp. 321-334
    • Lozzio, C.B.1    Lozzio, B.B.2
  • 29
    • 23844445433 scopus 로고    scopus 로고
    • Apoptin nuclear accumulation is modulated by a CRM1-recognized nuclear export signal that is active in normal but not in tumor cells
    • Poon IK, Oro C, Dias MM, Zhang J and Jans DA. Apoptin nuclear accumulation is modulated by a CRM1-recognized nuclear export signal that is active in normal but not in tumor cells. Cancer Res. 2005; 65(16):7059-7064.
    • (2005) Cancer Res , vol.65 , Issue.16 , pp. 7059-7064
    • Poon, I.K.1    Oro, C.2    Dias, M.M.3    Zhang, J.4    Jans, D.A.5
  • 33
    • 1442327629 scopus 로고    scopus 로고
    • TAT-apoptin is efficiently delivered and induces apoptosis in cancer cells
    • Guelen L, Paterson H, Gaken J, Meyers M, Farzaneh F and Tavassoli M. TAT-apoptin is efficiently delivered and induces apoptosis in cancer cells. Oncogene. 2004; 23(5):1153-1165.
    • (2004) Oncogene , vol.23 , Issue.5 , pp. 1153-1165
    • Guelen, L.1    Paterson, H.2    Gaken, J.3    Meyers, M.4    Farzaneh, F.5    Tavassoli, M.6
  • 35
    • 33846396238 scopus 로고    scopus 로고
    • Cytotoxic effects of intra- and extracellular zinc chelation on human breast cancer cells
    • Hashemi M, Ghavami S, Eshraghi M, Booy EP and Los M. Cytotoxic effects of intra- and extracellular zinc chelation on human breast cancer cells. Eur J Pharm. 2007; 557(1):9-19.
    • (2007) Eur J Pharm , vol.557 , Issue.1 , pp. 9-19
    • Hashemi, M.1    Ghavami, S.2    Eshraghi, M.3    Booy, E.P.4    Los, M.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.